SCHEMBL25033152

SCHEMBL25033152

CP(C)(=O)c1ccc(N)c2occc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24752718 0.71 CYP3A4 (0.33) —
SCHEMBL22595265 0.70 KCNA2 (0.34) —
SCHEMBL25033146 0.69 — —
SCHEMBL25032069 0.69 IDO1 (0.36) —
SCHEMBL5417588 0.67 KDM4E (0.30) —
SCHEMBL17774720 0.67 IDO1 (0.45) —
SCHEMBL31364787 0.67 NR4A2 (0.35) —
SCHEMBL7064960 0.67 IDO1 (0.50) —
SCHEMBL31304836 0.66 NPC1 (0.34) —
SCHEMBL24752719 0.66 KDM4E (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240400591-A1 COMPOUNDS TARGETING MUTANT OF P53 JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2024-12-05 — — US disclosed
WO-2023016434-A1 COMPOUNDS TARGETING MUTANT OF P53 JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2023-02-16 — — WO disclosed
Send feedback